YPB has overseas success with brand protection technology


Published 01-AUG-2019 12:54 P.M.


4 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

YPB Group Ltd (ASX:YPB) released its report for the June quarter on Thursday, but it could be argued that it was overshadowed by the important news that emerged earlier in the week.

The product authentication and consumer engagement solutions group announced on Monday that it had reached the significant milestone of over 100 million proprietary QR codes known as “ProtectCodes” issued to existing customers of the company’s Connect platform.

This represented another important milestone for the group which has continued to expand quickly in fiscal 2019.

In May, YPB announced that it had reached a milestone of 75 million “ProtectCodes” issued, a level that had been reached in around 24 months from the launch of Connect.

In the past two months, it has mainly been YPB’s cannabis and pharmaceutical customers that have been responsible for the accelerated uptick to 100 million, with over 29 million codes being issued in the past 60 days.

The company’s growth rate, as well as news that it had recently negotiated a Master Supply Agreement (MSA) with cannabis extraction specialist Halo Labs, has attracted significant investor interest.

The MSA was formalised in mid-July, and since then the company’s shares have doubled.

Management highlights cost controls and operational improvements

The trend of reduced cash consumption of approximately $800,000 continued in the June quarter with net operating cash burn falling 18% from the March quarter and 48% from the previous corresponding period in 2018.

Quarter on quarter reductions in staff costs of 27% and corporate overheads of 23% were the primary drivers of the improvement, and this can also be attributed to ongoing operational refinement and refocusing.

The improved June quarter result occurred despite a 33% fall in cash receipts on a quarter on quarter basis.

This partly reflected the timing of payments from passport-related sales, which are variable between quarters, but there was also a noticeable drop in Retail Anti-Theft (RAT) sales.

The competitiveness and price pressure in the RAT sector has intensified recently and, given the opportunities building in far higher quality authentication and engagement revenues, YPB’s RAT activities are presently under review.

Future quarters are expected to see the trend of falling cash burn continue.

Management said that further cost reductions will follow intense ongoing scrutiny on the value-generation of every cog in the business with the first important goal being a self-funding operation.

This represents astute prioritisation by management as it will assist the company in facilitating a change in product mix and strategic direction if required.

Focusing on resilient sectors

YPB indicated that it has narrowed its focus on sectors that are of a non-discretionary nature and/or those where brand protection is more essential.

This often sees the company developing relationships with overseas organisations where counterfeit risks are greater.

YPB has rekindled and struck new partnerships with key packaging suppliers to brands in order to gain leveraged market access and reach.

The group has also increased the robustness of its key ProtectCodeTM and Connect technologies, while refining its sales process.

Looking to the near to medium-term, YPB should benefit from the rollout of its Motif Micro technology which is very promising for the first iteration of smartphone yes/no scanning, and the company is on track to achieve a key milestone of curved surface readability.

Management still expects MM1 to be commercially ready by the end of 2019.

Smartphone readability of high integrity authentication marks is a generational technical leap with mass market applications.

Tamper proof technology in high demand

Curved surface readability is of value to all consumer brands but particularly so in health and beauty, and bottled goods such as wine.

On this note, the June quarter featured the co-launch of Vintail with Seppeltsfield one of Australia’s largest wine producers.

Vintail is a high-end authentication and engagement solution for premium wines where counterfeiting in export markets is a problem.

This technology is a highly innovative solution, solving multiple significant problems especially tamper evidence.

YPB’s Vintail solution is highly relevant to Australian wine exporters to China and Asia where a major issue is re-use and refilling of the originally exported wine bottles.

Another important achievement was the adoption of YPB tracer thread by one of the world’s largest cotton garment manufacturers, Esquel Group, in China.

In Indonesia, YPB has appointed PT Meidanum Imperii as a channel partner where it will focus on medical equipment and packaging for beauty, cosmetics, food, beverage and baby products.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free